Bayesian Capital Management, LP Agenus Inc Transaction History

Bayesian Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $6,489 - $11,741	10,300 New	10,300 $8,000
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $108,025 - $219,775	-74,500 Reduced 66.76%	37,100 $56,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $202,202 - $325,325	100,100 Added 870.43%	111,600 $267,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $8,428 - $13,502	-4,300 Reduced 27.22%	11,500 $24,000
Q2 2022 Aug 15, 2022	BUY	$1.3 - $2.64 $20,540 - $41,712	15,800 New	15,800 $31,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.